Viewing Study NCT04359706


Ignite Creation Date: 2025-12-26 @ 2:39 PM
Ignite Modification Date: 2025-12-29 @ 11:31 AM
Study NCT ID: NCT04359706
Status: COMPLETED
Last Update Posted: 2022-10-17
First Post: 2020-04-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19
Sponsor: University Hospital, Lille
Organization:

Study Overview

Official Title: Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With SARS-CoV2
Status: COMPLETED
Status Verified Date: 2020-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MICROVID
Brief Summary: Observational pilot single-center study aiming to determine the microbiota of critically ill patients infected with SARS-CoV-2. COVID-19 patients will be compared to historical critically ill controls with no SARS-CoV-2 infection.
Detailed Description: Observational pilot single-center study aiming to determine the microbiota of critically ill patients infected with SARS-CoV-2. COVID-19 patients will be compared to historical critically ill controls with no SARS-CoV-2 infection.

Respiratory and fecal microbiota (microbial and fungal) will be determined in COVID-19 patients on bronchoalveolar lavage and rectal swab.

Inflammatory biomarkers will also be measured in COVID-19 patients.

Characteristics of study patients will be collected at ICU admission and during ICU stay.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2020-A01042-37 OTHER ID-RCB number,ANSM View